Literature DB >> 2426301

Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients.

A Bellamy, A N Davison, M Feldmann.   

Abstract

In order to investigate the specificity of activated T cells in the cerebrospinal fluid (CSF) of patients with multiple sclerosis (MS), we have cultured cells in the presence of mitogen-free IL-2 but without any antigen. Two T cell lines have been derived and showed specific reactivity to certain purified gangliosides (GM1, GD1a, GD1b and GQ1b). However, responses to other brain and viral antigens were not seen, and neither were T cell lines from peripheral blood lymphocytes (PBL) of normal, MS or other neurological disease patients stimulated by these gangliosides. Release of IL-2 could be detected after incubation of these CSF lines with specific gangliosides. One line exhibited predominantly helper/inducer (T4+) phenotype whilst the other was suppressor/cytotoxic (T8+), and further analysis indicated it could be of the suppressor phenotype. These data may have implications for T cell-induced demyelination in MS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426301     DOI: 10.1016/0165-5728(86)90024-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  F T Rotteveel; C J Lucas
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 2.  Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides.

Authors:  G Y Ishioka; A G Lamont; D Thomson; N Bulbow; F C Gaeta; A Sette; H M Grey
Journal:  Springer Semin Immunopathol       Date:  1993

3.  T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo.

Authors:  C M Henningsson; S Selvaraj; G D MacLean; M R Suresh; A A Noujaim; B M Longenecker
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

5.  Detection of activated T lymphocytes in the human atherosclerotic plaque.

Authors:  G K Hansson; J Holm; L Jonasson
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

6.  Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells.

Authors:  S Corinti; R D De Palma; A Fontana; M C Gagliardi; C Gagliardi; C Pini; F Sallusto
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

Review 7.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

8.  Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis.

Authors:  R Martin; P Marquardt; S O'Shea; M Borkenstein; H W Kreth
Journal:  J Neuroimmunol       Date:  1989-06       Impact factor: 3.478

Review 9.  Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?

Authors:  A G Dalgleish; J K Fazakerley; H E Webb
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Jul-Aug       Impact factor: 8.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.